Think Bioscience
Develops small molecule drugs for historically challenging drug targets
$55MSeries A
Role not disclosedAV
AV8 Ventures
Activity from announced rounds
Activity in this selectionSeries A
AV8 Ventures is an investment firm with recorded relationships to Think Bioscience and Shennon Biotechnologies.
Recorded funding activity
Think Bioscience develops small-molecule medicines for historically difficult drug targets. Shennon develops precision T-cell engager immunotherapies for solid tumors. The two financing histories connect the firm to different drug-development approaches without establishing a complete sector or portfolio allocation.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $55M 1 disclosed · full round size, not this investor’s share